Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 2

Raltegravir: first in class HIV integrase inhibitor

Total article views   HTML views PDF downloads Totals
6,706 Dovepress* 6,706+ 1,887 8,593
Totals 6,706 1,887 8,593
*Since 11 April 2008
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on Google Scholar